Evidence map›Paper›PMID 37686084›Full record

ReviewInternational journal of molecular sciences2023

Pathogenic Relationships in Cystic Fibrosis and Renal Diseases: CFTR, SLC26A9 and Anoctamins.

Karl Kunzelmann, Jiraporn Ousingsawat, Andre Kraus, Julien H Park, Thorsten Marquardt, Rainer Schreiber, Björn Buchholz

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Karl KunzelmannPhysiological Institute, University of Regensburg, University Street 31, 93053 Regensburg, Germany.ORCID 0000-0001-6222-4593
Jiraporn OusingsawatPhysiological Institute, University of Regensburg, University Street 31, 93053 Regensburg, Germany.
Andre KrausDepartment of Nephrology and Hypertension, Friedrich Alexander University Erlangen Nuremberg, 91054 Erlangen, Germany.
Julien H ParkDepartment of Pediatrics, University Hospital Münster, 48149 Münster, Germany.ORCID 0000-0003-2305-9948
Thorsten MarquardtDepartment of Pediatrics, University Hospital Münster, 48149 Münster, Germany.
Rainer SchreiberPhysiological Institute, University of Regensburg, University Street 31, 93053 Regensburg, Germany.
Björn BuchholzDepartment of Nephrology and Hypertension, Friedrich Alexander University Erlangen Nuremberg, 91054 Erlangen, Germany.
University of Regensburg · DEFriedrich-Alexander-Universität Erlangen-Nürnberg · DEUniversity Hospital Münster · DE

Funding

Deutsche Forschungsgemeinschaft DFG Transregio-SFB, Project-ID 509149993, TRR 374 (Project A3).
6 · The paper itself

Abstract

The Cl

Indexed as

Cystic FibrosisPolycystic Kidney, Autosomal DominantPolycystic Kidney DiseasesAnoctaminsAntiportersCystic Fibrosis Transmembrane Conductance RegulatorHumansMembrane Transport ProteinsSulfate TransportersAnoctaminsAntiportersCFTR protein, humanCystic Fibrosis Transmembrane Conductance RegulatorMembrane Transport ProteinsSLC26A9 protein, humanSulfate TransportersanoctaminCFTRpendrinSLC26A9TMEM16ATMEM16F

Identifiers

PMID37686084
PMCPMC10487509
OpenAlexW4386221482

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.